These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 9884737)

  • 21. [Arrhythmogenesis of anti-arrhythmia drugs].
    Bayés de Luna A
    Rev Esp Cardiol; 1984; 37(4):233-5. PubMed ID: 6473865
    [No Abstract]   [Full Text] [Related]  

  • 22. [Current controversies concerning the use of calcium antagonists].
    Rossi G
    Recenti Prog Med; 1996 Mar; 87(3):114-7. PubMed ID: 8650431
    [No Abstract]   [Full Text] [Related]  

  • 23. The role of class III antiarrhythmic agents in maintaining sinus rhythm.
    Brachmann J
    Europace; 2000 Jul; 1 Suppl C():C10-5. PubMed ID: 11220519
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Therapy of cardiac arrhythmias].
    Rollo F; Materazzo F; Campanella V
    Clin Ter; 1981 Dec; 99(5):515-29. PubMed ID: 7037274
    [No Abstract]   [Full Text] [Related]  

  • 25. Problems in design and evaluation of antiarrhythmia trials.
    Prineas RJ
    Circulation; 1975 Dec; 52(6 Suppl):III248-57. PubMed ID: 1102146
    [No Abstract]   [Full Text] [Related]  

  • 26. [Cardiac arrhythmias (III). The classification of anti-arrhythmia drugs in the 90s: a focus for the cardiologist].
    Tamargo J; Valenzuela C; Delpón E
    Rev Esp Cardiol; 1993 Mar; 46(3):183-94. PubMed ID: 8387683
    [No Abstract]   [Full Text] [Related]  

  • 27. [Therapeutic possibilities in cardiac arrhythmias].
    Gasic S
    Wien Med Wochenschr; 1994; 144(14-15):337-8. PubMed ID: 7825323
    [No Abstract]   [Full Text] [Related]  

  • 28. [Serial review No.12 Calcium antagonist-improvement in the study of basic and clinical research-Calcium and arrhythmia].
    Atarashi H
    Clin Calcium; 2004 Mar; 14(3):454-6. PubMed ID: 15577007
    [No Abstract]   [Full Text] [Related]  

  • 29. Pro-arrhythmic effects of amiodarone and concomitant rate-control medication.
    Schrickel JW; Schwab JO; Yang A; Bielik H; Bitzen A; Lüderitz B; Lewalter T
    Europace; 2006 Jun; 8(6):403-7. PubMed ID: 16687421
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Calcium antagonists and their impact on coronary risk].
    Rodríguez Moreno C
    Med Clin (Barc); 1998 Feb; 110(6):237. PubMed ID: 9547737
    [No Abstract]   [Full Text] [Related]  

  • 31. Value and risk of class I and III antiarrhythmic drugs.
    Burkart F
    Pacing Clin Electrophysiol; 1994 Mar; 17(3 Pt 2):467-72. PubMed ID: 7513875
    [No Abstract]   [Full Text] [Related]  

  • 32. [Induction and increase of cardiac arrhythmia by anti-arrhythmia agents].
    Hohnloser SH; Meinertz T; Mehender M; Geibel A; Just H
    Internist (Berl); 1988 May; 29(5):338-44. PubMed ID: 3042675
    [No Abstract]   [Full Text] [Related]  

  • 33. [Proarrhythmia].
    Michel D
    Fortschr Med; 1987 Nov; 105(34):663-5. PubMed ID: 3428828
    [No Abstract]   [Full Text] [Related]  

  • 34. Drugs for cardiac arrhythmias.
    Treat Guidel Med Lett; 2004 Nov; 2(27):75-82. PubMed ID: 15529117
    [No Abstract]   [Full Text] [Related]  

  • 35. [Arrhythmias induced by antiarrhythmic drugs].
    Shinjo T; Ohe T
    Kokyu To Junkan; 1989 Apr; 37(4):415-9. PubMed ID: 2740644
    [No Abstract]   [Full Text] [Related]  

  • 36. [Classification of anti-arrhythmia agents and their characteristics].
    Hayakawa H
    Nihon Naika Gakkai Zasshi; 1991 Jul; 80(7):1022-5. PubMed ID: 1680943
    [No Abstract]   [Full Text] [Related]  

  • 37. [Effect of the novel III class anti-arrhythmia preparation (AL-275) in experimental myocardium and sympathetic stimulation].
    Kaverina NV; Lyskovtsev VV; Kishchuk EP
    Eksp Klin Farmakol; 2001; 64(1):33-7. PubMed ID: 11544801
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Arrhythmias caused by anti-arrhythmia agents].
    Platou ES; Skomedal T
    Tidsskr Nor Laegeforen; 1992 Jun; 112(15):1935-6. PubMed ID: 1509448
    [No Abstract]   [Full Text] [Related]  

  • 39. Antiarrhythmic drugs.
    Stewart RA
    N Z Med J; 1993 Apr; 106(954):161-3. PubMed ID: 8479666
    [No Abstract]   [Full Text] [Related]  

  • 40. [Guidelines for drug treatment of arrhythmias (JCS 2004)].
    Japanese Circulation Society Joint Working Groups for Guidelines for Diagnosis and Treatment of Cardiovascular Diseases
    J Cardiol; 2005 Feb; 45(2):325-47. PubMed ID: 15768611
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.